ASPI
ASP Isotopes Inc.
Price Chart
Latest Quote
$6.44
-0.20 (-3.01%)
Current Price
| Previous Close | $6.64 |
| Open | $6.62 |
| Day High | $6.85 |
| Day Low | $6.31 |
| Volume | 3,258,224 |
Stock Information
| Shares Outstanding | 125.90M |
| Total Debt | $261.84M |
| Cash Equivalents | $290.52M |
| Revenue | $26.93M |
| Net Income | $-193.11M |
| Sector | Basic Materials |
| Industry | Chemicals |
| Market Cap | $810.82M |
| EPS (TTM) | $-2.21 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $792.16M |
| Sales | $26.93M |
| Income | $-193.11M |
| Book/sh | $2.29 |
| Cash/sh | $2.31 |
| Employees | 271 |
Financial Ratios
| Quick Ratio | 4.19 |
| Current Ratio | 4.39 |
| Debt/Eq | 87.57 |
Returns & Margins
| ROA | -13.66% |
| ROE | -103.32% |
| Gross Margin | 17.62% |
| Operating Margin | -595.41% |
Ownership
| Insider Ownership | 13.19% |
| Institutional Ownership | 56.97% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -5.57 |
| P/S | 30.11 |
| P/B | 2.81 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $13.00 |
Technical Indicators
| SMA20 | $nan |
| SMA50 | $nan |
| SMA200 | $nan |
| RSI | 49.75 |
| ATR | nan |
| Shares Float | 95.85M |
| Short Float | 20.00% |
| Short Ratio | 4.27 |
| Volatility | 3.44 |
| Rel Volume | 0.51 |
Performance History
| Week | nan% |
| Month | nan% |
| Quarter | nan% |
| 6 Months | nan% |
| YTD | nan% |
| Year | nan% |
| 3 Years | nan% |
| 10 Years | nan% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-16 | $nan | 3,258,224 |
| 2026-06-15 | $6.64 | 4,948,600 |
| 2026-06-12 | $6.55 | 5,156,600 |
| 2026-06-11 | $6.23 | 4,308,500 |
| 2026-06-10 | $5.85 | 4,018,200 |
| 2026-06-09 | $6.40 | 6,459,300 |
| 2026-06-08 | $6.83 | 4,492,800 |
| 2026-06-05 | $6.71 | 8,390,600 |
| 2026-06-04 | $7.97 | 5,359,700 |
| 2026-06-03 | $7.55 | 6,329,300 |
| 2026-06-02 | $8.33 | 7,341,000 |
| 2026-06-01 | $8.01 | 7,555,800 |
| 2026-05-29 | $7.78 | 7,379,900 |
| 2026-05-28 | $7.77 | 11,820,500 |
| 2026-05-27 | $6.67 | 7,822,400 |
| 2026-05-26 | $6.93 | 14,028,100 |
| 2026-05-22 | $5.55 | 5,037,400 |
| 2026-05-21 | $5.17 | 5,079,300 |
| 2026-05-20 | $5.26 | 3,822,300 |
| 2026-05-19 | $4.84 | 4,313,500 |
| 2026-05-18 | $5.28 | 4,530,200 |
About ASP Isotopes Inc.
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods used to separate high-value, low-volume isotopes, such as C-14, Mo-100 and Si-28, for target end markets, including pharmaceuticals and agrochemicals, nuclear medical imaging, and semiconductors; provision of related services; and operation of PET labs. The company offers the Aerodynamic Separation Process (ASP) technology, which separates gas species and isotopes in a volatile state; and the Quantum Enrichment (QE) technology, which separates isotopes. It also produces and commercializes Molybdenum-100, Molybdenum-98, and Ytterbium-176 for the nuclear medical industry. In addition, the company develops Zinc-68, Nickel-64, and Xenon-129/136 for the nuclear medical industry; Lithium-7, Uranium-235, and Chlorine-37 for the energy industry; and Germanium-70/72/74 for semiconductor markets. The company was incorporated in 2021 and is based in Dallas, Texas.
đ° Latest News
Manhattan Uranium Gains Approval to Advance Drilling at Nevada Uranium Project
Insider Monkey âĸ 2026-06-09T21:52:24Z
ASP Isotopes (ASPI) Restarts Silicon-28 Facility Stages After Upgrades â What Does It Signal?
Simply Wall St. âĸ 2026-06-09T00:17:17Z
ASPI Stock Heads For Best Gains In 7 Months â Why Are Investors Excited About ASP Isotopes Restarting Its Silicon Facility?
Stocktwits âĸ 2026-05-26T14:47:44Z
Does ASP Isotopesâ New LNG, Radiopharmacy, and Quantum Plant Strategy Change The Bull Case For ASPI?
Simply Wall St. âĸ 2026-05-25T04:29:48Z
Assessing ASP Isotopes (ASPI) Valuation After HALEU Collaboration MOU With European Reactor Developer
Simply Wall St. âĸ 2026-05-14T18:23:41Z
ASP Isotopes (ASPI) Announces New Business Update
Insider Monkey âĸ 2026-04-21T19:26:49Z
April 2026's Top Growth Companies With Strong Insider Ownership
Simply Wall St. âĸ 2026-04-13T17:35:59Z
ASP Isotopes Q4 Earnings Call Highlights
MarketBeat âĸ 2026-04-13T14:36:55Z
The Future of Uranium Enrichment is Being Developed Today
ETF Trends âĸ 2026-04-13T11:00:11Z
ASP Isotopes (ASPI) Balances HALEU Ambitions With Securities Suit Progression â What Does It Signal?
Simply Wall St. âĸ 2026-03-17T00:20:22Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $20,444,000 | $2,545,000 | $294,056 | $0 |
| Cost Of Revenue | $20,444,000 | $2,545,000 | $294,056 | $0 |
| Total Revenue | $23,849,000 | $4,144,000 | $433,026 | $0 |
| Operating Revenue | $23,849,000 | $4,144,000 | $433,026 | $0 |
| Expenses | ||||
| Interest Expense | $575,000 | $259,000 | $118,547 | $0 |
| Total Expenses | $81,040,000 | $30,498,000 | $16,475,025 | $5,099,048 |
| Other Income Expense | $-108,585,000 | $-6,937,000 | $-148,787 | $150,527 |
| Other Non Operating Income Expenses | $-123,666,000 | $-7,007,000 | $-194,540 | $150,527 |
| Net Non Operating Interest Income Expense | $6,215,000 | $979,000 | $-109,473 | $3,382 |
| Interest Expense Non Operating | $575,000 | $259,000 | $118,547 | $0 |
| Operating Expense | $60,596,000 | $27,953,000 | $16,180,969 | $5,099,048 |
| General And Administrative Expense | $48,238,000 | $24,814,000 | $15,416,388 | $3,825,512 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-175,092,000 | $-32,334,000 | $-16,286,234 | $-4,945,139 |
| Net Interest Income | $6,215,000 | $979,000 | $-109,473 | $3,382 |
| Interest Income | $6,790,000 | $1,238,000 | $9,074 | $3,382 |
| Normalized Income | $-187,005,990 | $-32,389,300 | $-16,331,973 | $-5,095,666 |
| Net Income From Continuing And Discontinued Operation | $-175,092,000 | $-32,334,000 | $-16,286,234 | $-4,945,139 |
| Total Operating Income As Reported | $-59,908,000 | $-26,354,000 | $-16,041,999 | $-5,099,048 |
| Net Income Common Stockholders | $-175,092,000 | $-35,114,000 | $-16,286,234 | $-4,945,139 |
| Net Income | $-175,092,000 | $-32,334,000 | $-16,286,234 | $-4,945,139 |
| Net Income Including Noncontrolling Interests | $-159,843,000 | $-32,423,000 | $-16,294,126 | $-4,945,139 |
| Net Income Continuous Operations | $-159,843,000 | $-32,423,000 | $-16,294,126 | $-4,945,139 |
| Pretax Income | $-159,561,000 | $-32,312,000 | $-16,300,259 | $-4,945,139 |
| Special Income Charges | $-2,717,000 | $0 | - | - |
| Interest Income Non Operating | $6,790,000 | $1,238,000 | $9,074 | $3,382 |
| Operating Income | $-57,191,000 | $-26,354,000 | $-16,041,999 | $-5,099,048 |
| Gross Profit | $3,405,000 | $1,599,000 | $138,970 | $0 |
| Per Share | ||||
| Diluted EPS | $-2.11 | $-0.63 | $-0.49 | $-0.18 |
| Basic EPS | $-2.11 | $-0.63 | $-0.49 | $-0.18 |
| Other | ||||
| Tax Effect Of Unusual Items | $3,167,010 | $14,700 | $14 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-172,155,000 | $-31,652,000 | $-16,190,032 | $-5,095,666 |
| Total Unusual Items | $15,081,000 | $70,000 | $45,753 | $150,527 |
| Total Unusual Items Excluding Goodwill | $15,081,000 | $70,000 | $45,753 | $150,527 |
| Reconciled Depreciation | $1,912,000 | $471,000 | $37,433 | $0 |
| EBITDA (Bullshit earnings) | $-157,074,000 | $-31,582,000 | $-16,144,279 | $-4,945,139 |
| EBIT | $-158,986,000 | $-32,053,000 | $-16,181,712 | $-4,945,139 |
| Diluted Average Shares | $83,013,594 | $55,671,805 | $33,066,708 | $26,793,748 |
| Basic Average Shares | $83,013,594 | $55,671,805 | $33,066,708 | $26,793,748 |
| Diluted NI Availto Com Stockholders | $-175,092,000 | $-35,114,000 | $-16,286,234 | $-4,945,139 |
| Otherunder Preferred Stock Dividend | $0 | $2,780,000 | $0 | - |
| Minority Interests | $-15,249,000 | $89,000 | $7,892 | $0 |
| Tax Provision | $282,000 | $111,000 | $-6,133 | $0 |
| Other Special Charges | $2,717,000 | - | - | - |
| Gain On Sale Of Security | $17,798,000 | $70,000 | $45,753 | $150,527 |
| Research And Development | $12,358,000 | $3,139,000 | $764,581 | $1,273,536 |
| Selling General And Administration | $48,238,000 | $24,814,000 | $15,416,388 | $3,825,512 |
| Other Gand A | $48,238,000 | $24,814,000 | $15,416,388 | $3,825,512 |
Fetched: 2026-06-08
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $194,103,000 | $44,731,000 | $13,028,851 | $9,817,461 |
| Total Assets | $498,020,000 | $94,348,000 | $27,541,913 | $12,496,265 |
| Total Non Current Assets | $98,101,000 | $28,604,000 | $17,031,657 | $9,194,120 |
| Other Non Current Assets | $5,357,000 | $1,928,000 | $1,793,014 | $139,636 |
| Non Current Deferred Assets | $0 | $32,000 | $0 | - |
| Non Current Deferred Taxes Assets | $0 | $32,000 | $0 | - |
| Non Current Accounts Receivable | $426,000 | - | - | - |
| Goodwill And Other Intangible Assets | $10,048,000 | $3,168,000 | $3,267,103 | $0 |
| Other Intangible Assets | $1,478,000 | - | - | - |
| Current Assets | $399,919,000 | $65,744,000 | $10,510,256 | $3,302,145 |
| Other Current Assets | $1,135,000 | $1,478,000 | $1,664,023 | $913,005 |
| Current Deferred Assets | $1,782,000 | $0 | - | - |
| Prepaid Assets | $10,886,000 | $0 | - | - |
| Inventory | $1,098,000 | $66,000 | $0 | - |
| Receivables | $51,710,000 | $2,310,000 | $938,052 | $0 |
| Other Receivables | $1,060,000 | - | - | - |
| Taxes Receivable | $763,000 | $1,575,000 | - | - |
| Notes Receivable | $32,005,000 | $0 | - | - |
| Accounts Receivable | $17,882,000 | $707,000 | $216,504 | $0 |
| Cash Cash Equivalents And Short Term Investments | $333,308,000 | $61,890,000 | $7,908,181 | $2,389,140 |
| Cash And Cash Equivalents | $285,563,000 | $61,890,000 | $7,908,181 | $2,389,140 |
| Cash Financial | - | - | $7,908,181 | $2,389,140 |
| Debt | ||||
| Total Debt | $215,960,000 | $37,745,000 | $2,142,640 | $822,200 |
| Long Term Debt And Capital Lease Obligation | $202,324,000 | $36,122,000 | $1,273,739 | $742,443 |
| Long Term Debt | $200,794,000 | $34,874,000 | - | - |
| Current Debt And Capital Lease Obligation | $13,636,000 | $1,623,000 | $868,901 | $79,757 |
| Current Debt | $12,885,000 | $939,000 | $470,396 | $33,854 |
| Other Current Borrowings | $12,885,000 | $939,000 | $470,396 | $33,854 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $235,122,000 | $43,181,000 | $8,711,282 | $2,678,804 |
| Total Non Current Liabilities Net Minority Interest | $202,426,000 | $36,122,000 | $3,037,317 | $742,443 |
| Non Current Deferred Liabilities | $102,000 | $0 | $110,578 | $0 |
| Non Current Deferred Taxes Liabilities | $102,000 | $0 | $110,578 | $0 |
| Current Liabilities | $32,696,000 | $7,059,000 | $5,673,965 | $1,936,361 |
| Other Current Liabilities | $2,037,000 | $1,257,000 | $1,500,000 | $140,455 |
| Current Deferred Liabilities | $882,000 | $882,000 | $882,000 | $0 |
| Payables And Accrued Expenses | $16,141,000 | $3,297,000 | $2,423,064 | $1,716,149 |
| Payables | $9,917,000 | $1,021,000 | $1,111,819 | $1,354,903 |
| Accounts Payable | $5,755,000 | $1,021,000 | $1,111,819 | $1,354,903 |
| Other Non Current Liabilities | - | - | $1,653,000 | - |
| Current Notes Payable | - | - | $470,396 | $33,854 |
| Equity | ||||
| Common Stock Equity | $204,151,000 | $47,899,000 | $16,295,954 | $9,817,461 |
| Total Equity Gross Minority Interest | $262,898,000 | $51,167,000 | $18,830,631 | $9,817,461 |
| Stockholders Equity | $204,151,000 | $47,899,000 | $16,295,954 | $9,817,461 |
| Gains Losses Not Affecting Retained Earnings | $2,542,000 | $-2,164,000 | $-920,982 | $255,030 |
| Other Equity Adjustments | $2,542,000 | $-2,164,000 | $-920,982 | $255,030 |
| Retained Earnings | $-231,265,000 | $-56,173,000 | $-23,839,300 | $-7,553,066 |
| Long Term Equity Investment | $1,327,000 | $0 | - | - |
| Investments In Other Ventures Under Equity Method | $1,327,000 | $0 | - | - |
| Other | ||||
| Ordinary Shares Number | $111,677,771 | $72,068,059 | $48,923,276 | $35,907,127 |
| Share Issued | $111,677,771 | $72,068,059 | $48,923,276 | $35,907,127 |
| Tangible Book Value | $194,103,000 | $44,731,000 | $13,028,851 | $9,817,461 |
| Invested Capital | $417,830,000 | $83,712,000 | $16,766,350 | $9,851,315 |
| Working Capital | $367,223,000 | $58,685,000 | $4,836,291 | $1,365,784 |
| Capital Lease Obligations | $2,281,000 | $1,932,000 | $1,672,244 | $788,346 |
| Total Capitalization | $404,945,000 | $82,773,000 | $16,295,954 | $9,817,461 |
| Minority Interest | $58,747,000 | $3,268,000 | $2,534,677 | $0 |
| Additional Paid In Capital | $431,757,000 | $105,515,000 | $40,567,003 | $16,756,426 |
| Capital Stock | $1,117,000 | $721,000 | $489,233 | $359,071 |
| Common Stock | $1,117,000 | $721,000 | $489,233 | $359,071 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $1,530,000 | $1,248,000 | $1,273,739 | $742,443 |
| Current Deferred Revenue | $882,000 | $882,000 | $882,000 | $0 |
| Current Capital Lease Obligation | $751,000 | $684,000 | $398,505 | $45,903 |
| Current Accrued Expenses | $6,224,000 | $2,276,000 | $1,311,245 | $361,246 |
| Dueto Related Parties Current | $4,162,000 | $0 | - | - |
| Investments And Advances | $47,306,000 | $0 | - | - |
| Other Investments | $45,979,000 | $0 | - | - |
| Goodwill | $8,570,000 | $3,168,000 | $3,267,103 | $0 |
| Net PPE | $34,964,000 | $23,476,000 | $11,971,540 | $9,054,484 |
| Accumulated Depreciation | $-2,999,000 | $-486,000 | $-37,707 | $0 |
| Gross PPE | $37,963,000 | $23,962,000 | $12,009,247 | $9,054,484 |
| Leases | $137,000 | $116,000 | $21,446 | $0 |
| Construction In Progress | $4,950,000 | $13,970,000 | $9,108,923 | $8,200,595 |
| Other Properties | $1,512,000 | $1,122,000 | $1,258,701 | $853,889 |
| Machinery Furniture Equipment | $31,364,000 | $8,754,000 | $1,620,177 | $0 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $0 | $0 | - | - |
| Work In Process | $614,000 | $0 | - | - |
| Raw Materials | $484,000 | $66,000 | - | - |
| Duefrom Related Parties Current | $0 | $28,000 | $721,548 | $0 |
| Other Short Term Investments | $47,745,000 | - | - | - |
Fetched: 2026-06-08
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-47,434,000 | $-28,068,000 | $-7,743,735 | $-7,413,057 |
| Operating Activities | ||||
| Operating Cash Flow | $-37,780,000 | $-16,696,000 | $-5,412,392 | $-2,939,893 |
| Cash Flow From Continuing Operating Activities | $-37,780,000 | $-16,696,000 | $-5,412,392 | $-2,939,893 |
| Operating Gains Losses | - | $44,000 | $-44,649 | - |
| Investing Activities | ||||
| Capital Expenditure | $-9,654,000 | $-11,372,000 | $-2,331,343 | $-4,473,164 |
| Investing Cash Flow | $-110,794,000 | $-11,372,000 | $-2,453,191 | $-4,473,164 |
| Cash Flow From Continuing Investing Activities | $-110,794,000 | $-11,372,000 | $-2,453,191 | $-4,473,164 |
| Net Other Investing Changes | $-29,974,000 | - | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $320,304,000 | $53,091,000 | $14,129,495 | $8,119,959 |
| Financing Cash Flow | $371,600,000 | $82,534,000 | $13,385,491 | $6,641,452 |
| Cash Flow From Continuing Financing Activities | $371,600,000 | $82,534,000 | $13,385,491 | $6,641,452 |
| Net Other Financing Charges | $4,834,000 | $-2,119,000 | $-563,473 | $-1,465,461 |
| Net Common Stock Issuance | $320,304,000 | $53,091,000 | $14,129,495 | $8,119,959 |
| Common Stock Issuance | $320,304,000 | $53,091,000 | $14,129,495 | $8,119,959 |
| Other | ||||
| Repayment Of Debt | $-16,136,000 | $-713,000 | $-706,813 | $-13,046 |
| Issuance Of Debt | $57,677,000 | $26,437,000 | $526,282 | $0 |
| Income Tax Paid Supplemental Data | $79,000 | $0 | - | - |
| End Cash Position | $285,563,000 | $61,890,000 | $7,908,181 | $2,389,140 |
| Beginning Cash Position | $61,890,000 | $7,908,000 | $2,389,140 | $2,953,721 |
| Effect Of Exchange Rate Changes | $647,000 | $-484,000 | $-867 | $207,424 |
| Changes In Cash | $223,026,000 | $54,466,000 | $5,519,908 | $-772,005 |
| Proceeds From Stock Option Exercised | $4,921,000 | $5,838,000 | $0 | - |
| Net Issuance Payments Of Debt | $41,541,000 | $25,724,000 | $-180,531 | $-13,046 |
| Net Long Term Debt Issuance | $41,541,000 | $25,724,000 | $-92,818 | $-13,046 |
| Long Term Debt Payments | $-16,136,000 | $-713,000 | $-619,100 | $-13,046 |
| Long Term Debt Issuance | $57,677,000 | $26,437,000 | $526,282 | $0 |
| Net Investment Purchase And Sale | $-47,745,000 | $0 | - | - |
| Purchase Of Investment | $-47,745,000 | $0 | - | - |
| Net Business Purchase And Sale | $-23,421,000 | $0 | $-121,848 | $0 |
| Sale Of Business | $4,574,000 | $0 | - | - |
| Purchase Of Business | $-27,995,000 | $0 | $-121,848 | $0 |
| Net PPE Purchase And Sale | $-9,654,000 | $-11,372,000 | $-2,331,343 | $-4,473,164 |
| Purchase Of PPE | $-9,654,000 | $-11,372,000 | $-2,331,343 | $-4,473,164 |
| Change In Working Capital | $-3,629,000 | $-2,622,000 | $1,159,728 | $33,890 |
| Change In Other Current Liabilities | $-2,603,000 | $-715,000 | $18,877 | $-37,399 |
| Change In Other Current Assets | $1,220,000 | $-9,000 | $-59,324 | $-146,435 |
| Change In Payables And Accrued Expense | $1,352,000 | $33,000 | $626,320 | $889,648 |
| Change In Accrued Expense | $570,000 | $910,000 | $873,705 | $319,048 |
| Change In Payable | $782,000 | $-877,000 | $-247,385 | $570,600 |
| Change In Account Payable | $782,000 | $-877,000 | $-224,598 | $570,600 |
| Change In Prepaid Assets | $-2,829,000 | $-1,357,000 | $-546,097 | $-671,924 |
| Change In Inventory | $-315,000 | $-68,000 | $0 | - |
| Change In Receivables | $-454,000 | $-506,000 | $237,952 | $0 |
| Changes In Account Receivables | $-482,000 | $-506,000 | $237,952 | $0 |
| Other Non Cash Items | $1,835,000 | $2,409,000 | $774,228 | $122,570 |
| Stock Based Compensation | $16,024,000 | $8,561,000 | $8,743,799 | $1,999,313 |
| Unrealized Gain Loss On Investment Securities | $105,908,000 | $7,007,000 | $194,540 | $-150,527 |
| Provisionand Write Offof Assets | $58,000 | $0 | - | - |
| Deferred Tax | $-45,000 | $-143,000 | $16,655 | $0 |
| Deferred Income Tax | $-45,000 | $-143,000 | $16,655 | $0 |
| Depreciation Amortization Depletion | $1,912,000 | $471,000 | $37,433 | $0 |
| Depreciation And Amortization | $1,912,000 | $471,000 | $37,433 | $0 |
| Depreciation | $1,912,000 | $471,000 | $37,433 | $0 |
| Net Foreign Currency Exchange Gain Loss | $0 | $42,000 | $-44,649 | $0 |
| Gain Loss On Sale Of PPE | $0 | $2,000 | $0 | - |
| Net Income From Continuing Operations | $-159,843,000 | $-32,423,000 | $-16,294,126 | $-4,945,139 |
| Net Short Term Debt Issuance | - | $-561,176 | $-87,713 | $0 |
| Short Term Debt Payments | - | $-561,176 | $-87,713 | $0 |
| Short Term Debt Issuance | - | $500,923 | $526,282 | $0 |
| Change In Tax Payable | - | $0 | $-22,787 | $0 |
| Change In Income Tax Payable | - | $0 | $-22,787 | $0 |
| Change In Other Working Capital | - | - | $882,000 | - |
Fetched: 2026-06-08